N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide

C69H69IN8O7 — CID 155546958

IUPACN-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide
SMILESCCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2cccc([124I])c2)=C5C)[C@@H](C)[C@@H]4CCC(=O)NCc2cccc(C#Cc4cccc(Nc5ncnc6cc(OCCOC)c(OCCOC)cc56)c4)c2)C3=N1
InChIInChI=1S/C69H69IN8O7/c1-9-50-39(2)54-34-60-65(43(6)85-37-47-16-11-17-48(70)28-47)41(4)56(76-60)32-55-40(3)51(67(77-55)53-30-61(79)66-42(5)57(78-68(53)66)33-59(50)75-54)21-22-64(80)71-36-46-15-10-13-44(27-46)19-20-45-14-12-18-49(29-45)74-69-52-31-62(83-25-23-81-7)63(84-26-24-82-8)35-58(52)72-38-73-69/h10-18,27-29,31-35,38,40,43,51,77,79H,9,21-26,30,36-37H2,1-8H3,(H,71,80)(H,72,73,74)/b55-32-,59-33-,60-34-,67-53-/t40-,43?,51-/m0/s1/i70-3
InChIKeyFBBUDAHZQBAICN-RAOHOMSGSA-N
MW1246.27 g/mol
LogP13.10
Rot. Bonds20

About N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide

N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide (PubChem CID 155546958) has the molecular formula C69H69IN8O7 and a molecular weight of 1246.27 g/mol. Its IUPAC name is N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide.

Molecular Properties

Compound NameN-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide
PubChem CID155546958
Molecular FormulaC69H69IN8O7
Molecular Weight1246.27 g/mol
Exact Mass1245.44
IUPAC NameN-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide
SMILESCCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2cccc([124I])c2)=C5C)[C@@H](C)[C@@H]4CCC(=O)NCc2cccc(C#Cc4cccc(Nc5ncnc6cc(OCCOC)c(OCCOC)cc56)c4)c2)C3=N1
InChIInChI=1S/C69H69IN8O7/c1-9-50-39(2)54-34-60-65(43(6)85-37-47-16-11-17-48(70)28-47)41(4)56(76-60)32-55-40(3)51(67(77-55)53-30-61(79)66-42(5)57(78-68(53)66)33-59(50)75-54)21-22-64(80)71-36-46-15-10-13-44(27-46)19-20-45-14-12-18-49(29-45)74-69-52-31-62(83-25-23-81-7)63(84-26-24-82-8)35-58(52)72-38-73-69/h10-18,27-29,31-35,38,40,43,51,77,79H,9,21-26,30,36-37H2,1-8H3,(H,71,80)(H,72,73,74)/b55-32-,59-33-,60-34-,67-53-/t40-,43?,51-/m0/s1/i70-3
InChIKeyFBBUDAHZQBAICN-RAOHOMSGSA-N
XLogP13.10
TPSA182.40 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds20
Heavy Atoms85
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001246.27
LogP ≤ 513.10
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide?
The IUPAC name of N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide (CID 155546958) is N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide.
What is the SMILES notation for N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide?
The canonical SMILES for N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide is CCC1=C(C)C2=N/C1=C\C1=C(C)C3=C(O)C/C(=C4/N/C(=C\C5=N/C(=C\2)C(C(C)OCc2cccc([124I])c2)=C5C)[C@@H](C)[C@@H]4CCC(=O)NCc2cccc(C#Cc4cccc(Nc5ncnc6cc(OCCOC)c(OCCOC)cc56)c4)c2)C3=N1.
What is the InChIKey of N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide?
The InChIKey is FBBUDAHZQBAICN-RAOHOMSGSA-N. The full InChI is InChI=1S/C69H69IN8O7/c1-9-50-39(2)54-34-60-65(43(6)85-37-47-16-11-17-48(70)28-47)41(4)56(76-60)32-55-40(3)51(67(77-55)53-30-61(79)66-42(5)57(78-68(53)66)33-59(50)75-54)21-22-64(80)71-36-46-15-10-13-44(27-46)19-20-45-14-12-18-49(29-45)74-69-52-31-62(83-25-23-81-7)63(84-26-24-82-8)35-58(52)72-38-73-69/h10-18,27-29,31-35,38,40,43,51,77,79H,9,21-26,30,36-37H2,1-8H3,(H,71,80)(H,72,73,74)/b55-32-,59-33-,60-34-,67-53-/t40-,43?,51-/m0/s1/i70-3.
What are the key properties of N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide?
N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide has a molecular weight of 1246.27 g/mol, XLogP of 13.10, 20 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[3-[2-[3-[[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amino]phenyl]ethynyl]phenyl]methyl]-3-[(21S,22S)-11-ethyl-4-hydroxy-16-[1-[(3-(124I)iodophenyl)methoxy]ethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanamide is sourced from PubChem (CID 155546958), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).